Patient with mental illnesses such as schizophrenia and bipolar disorder have an increased prevalence of metabolic syndrome (MetS) and its components compared to general population. Among psychiatric disorders, bipolar disorder ranks highest in suicidality with a relative risk ratio of completed suicide of about 25 compared to the general population. Regarding the biological hypotheses of suicidality, low blood cholesterol level has been extensively explored, although results are still conflicting. The aim of this study was to investigate whether there were differences in the serum cholesterol levels in hospitalized bipolar disorder men patients with history of suicide attempts (N = 20) and without suicide attempts (N = 20). Additionally, we investigated if there were differences in the prevalence of MetS according to NCEP ATP-III criteria in these two groups of patients. Results of the study indicated significantly lower serum cholesterol levels (p = 0.013) and triglyceride levels (p = 0.047), in the bipolar disorder men with suicide attempts in comparison to bipolar disorder men without suicide attempts. The overall prevalence of MetS was 11/40 (27.5%). On this particular sample it was higher in the non-attempters 8/20 (40.0%) than in attempters 3/20 (15.0%) bipolar men group, but without statistical significance. Lower concentrations of serum cholesterol might be useful biological markers of suicidality in men with bipolar disorder.
Introduction
Patient with mental illnesses such as schizophrenia and bipolar disorder have an increased prevalence of metabolic syndrome (MetS) and its components, risk factors for cardiovascular disease and type 2 diabetes (Ryan and Thakore, 2002; Newcomer, 2007) compared to general population in which incidence of MetS is also rising at an alarming rate (Nuggent, 2004) . Although in the past years more attention has been devoted to the medical burden suffered by patients with schizophrenia, very recently similar concern have arisen for bipolar disorder patients. Previous studies on the prevalence of MetS in bipolar patients found 30% and 49% prevalence of MetS in US bipolar patients (Fagiollini et al., 2005; Cardenas et al., 2008) , 32% prevalence of MetS in Turkish bipolar patients (Yumru et al., 2007) and 22.4% in Spanish bipolar patients (Garcia-Portilla et al., 2008) . The etiology associated with this increased risk of MetS in bipolar disorder is unknown. In addition to psychosocial factors such as poverty, poor diet, lack of physical activities, increasing concern has focused on the association between second generation antipsychotics, weight gain and subsequent risk of hyperlipidaemia and diabetes. Patients with bipolar disorder have an additional risk for developing MetS because of hyperphagia and psychomotor retardation in atypical depression or comorbid conditions such as eating disorders, particularly within the bulimia/binge eating spectrum (McElroy et al., 2006) . Fagiollini et al. (2005) found that bipolar patients with MetS and patients endorsing the obesity criterion were more likely to report a lifetime history of suicide attempts.
Among psychiatric disorders, bipolar disorder ranks highest in suicidality with a relative risk ratio of completed suicide of about 25 compared to the general population (Baldessarini and Tondo, 2003) . During their lifetime 80% of patients with bipolar disorder exhibit suicidal behaviour and 51% attempt suicide (Valtonen et al., 2005) . The high lethality of suicidal acts in bipolar disorder is suggested by a much lower ratio of attempts: suicide (3:1) than in the general population (30:1) (Baldessarini et al., 2006) . Compared with unipolar patients, suicide attempts in bipolar patients tend to be more lethal, particularly in males (Zalsman et al., 2006) .
